Telescope Therapeutics
PrivateLast Round
Accelerator
Nov 14, 2025
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Telescope Therapeutics operates in Healthcare & Life Sciences and is based in Montreal. Its latest recorded funding round was an Accelerator round in November 2025.
Telescope Therapeutics is a biotechnology company that develops a drug discovery platform using human iPSC-derived disease models and biosensor-based phenotypic evaluation to identify treatments for fibrotic diseases.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Telescope Therapeutics Comparables
Compare Telescope Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Curi Bio | 79% | |
| HeartBeat.bio AG | 78% | |
| Vivodyne | 78% |
For institutional investors. Book with your work email.
Telescope Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Telescope Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| LvlUp Ventures | Accelerator |
| McGill Dobson Centre for Entrepreneurship | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 14, 2025
Secured funding from LvlUp Ventures and McGill Dobson Centre for Entrepreneurship.
- Jul 17, 2025
Grew 75% QoQ, from 4 to 7 employees.
For institutional investors. Book with your work email.
Telescope Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Telescope Therapeutics's valuation, stock price, and market status.
Is Telescope Therapeutics a public or private company?
Telescope Therapeutics is a private company.
What is the current stock price of Telescope Therapeutics?
Telescope Therapeutics is a private company, so its shares have no public market price. Caplight tracks Telescope Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Telescope Therapeutics worth (valuation)?
Valuation information for Telescope Therapeutics is not publicly available.
Can I buy Telescope Therapeutics stock?
Telescope Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Telescope Therapeutics's last funding round?
Telescope Therapeutics's most recent funding round was Accelerator on November 14, 2025.
Who are the main investors in Telescope Therapeutics?
Key investors in Telescope Therapeutics include LvlUp Ventures, McGill Dobson Centre for Entrepreneurship.
Will Telescope Therapeutics IPO soon?
No public IPO plans have been announced for Telescope Therapeutics.
How can I track Telescope Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Telescope Therapeutics's shares on secondary markets.